Study of Individual Weight-bearing and Iterative Walking Using "ComeBack Mobility" Smart Crutch Tips for Mechanical Stimulation of Tibial Shaft Fracture Healing.

Comeback Mobility Inc29 个研究点分布在 1 个国家目标入组 30 人开始时间: 2025年10月28日最近更新: 2026年4月14日

干预措施

试验速览

阶段: 不适用
状态: 招募中
发起方
入组人数: 30
试验地点: 29
主要终点: Time to Radiographic Fracture Union

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The goal of this clinical trial is to learn whether personalized weight-bearing prescriptions using Smart Crutch Tips™ can improve recovery after surgery for tibial shaft fractures. The study will also assess how safe and practical this approach is in daily outpatient use.

Can a personalized weight-bearing program based on CT and finite element analysis help the fracture heal faster? Can it help patients return to full weight-bearing sooner? Can it reduce the fear of movement during recovery? Does iterative walking in the early postoperative period support faster or better bone healing? Researchers will compare standard rehabilitation to different types of personalized weight-bearing programs to see which leads to faster healing, earlier mobility, and better outcomes.

Participants will:

Use Smart Crutch Tips™ during walking for up to 24 weeks; Follow a personalized weight-bearing prescription based on CT scans and biomechanical modeling; Follow a specific walking plan with real-time audio and visual feedback; Attend six follow-up visits over 36 weeks for clinical exams, x-rays, and CT scans; Complete online questionnaires about pain, activity, and fear of movement.

详细描述

This is a pilot multicenter clinical trial designed to explore the impact of individual weight-bearing and iterative walking regimens on the healing of tibial shaft fractures. The study will enroll 30 adult participants (aged 18 to 80) with closed tibial shaft fractures (AO/OTA 42-A, 42-B, or 42-C) treated by intramedullary nailing and/or plate fixation. Participants will be allocated into three parallel groups (ten participants per group), two of whom will receive personalized weight-bearing protocols based on finite element analysis (FEA) performed using individual CT scan data.

The goal of the study is to determine whether providing precise, data-driven weight-bearing recommendations-delivered through Smart Crutch Tips™ with real-time visual and auditory feedback-can enhance fracture healing by promoting safe interfragmentary motion.

Group 1 (control - standard practice) will use Smart Crutch Tips™ for load data collection only, without feedback, and follow AO Foundation guidelines, progressing weight-bearing based on pain tolerance.

Group 2 (controlled mechanical stimulation) will receive personalized FEA-based load prescriptions for optimal interfragmentary motion, with real-time audio/visual feedback from Smart Crutch Tips™. They will perform iterative walking sessions (minimum two-hour rest between), gradually increasing steps per their plan, plus prescribed lower limb strengthening exercises.

Group 3 (optimized stimulation per Claes-Heigele theory) will receive FEA-based prescriptions targeting maximum fracture-zone voxel optimization, with real-time feedback. They will follow the same walking and exercise protocol as Group 2.

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Parallel
主要目的: Treatment
盲法: Single (Outcomes Assessor)

盲法说明

Data analysts, FEA specialists and radiologists will also be blinded to group allocation until the database lock

入排标准

年龄范围: 18 Years 至 80 Years（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Signed informed consent was provided after being fully informed about participation in the study.
•Age: 18 to 80 years for both males and females (pre-menopausal).
•Body weight between 40 and 120 kg.
•Body Mass Index (BMI) between 18.5 and 29.9 kg/m².
•Diagnosed with a closed tibial shaft fracture (AO/OTA classification: 42-A, 42-B, or 42-C) requiring surgical treatment.
•Fracture treated exclusively with intramedullary nailing and/or plate fixation
•No diabetes or well-controlled diabetes (HbA1c ≤ 7.0%).
•Ability to use crutches without losing balance and medically cleared for partial weight-bearing on the operated limb.
•Willingness to adhere to the prescribed weight-bearing protocol using the Smart Crutch Tips™ device.
•Enrollment within 48 hours following surgical intervention.
•Alcohol consumption (up to 2-3 times per week) within acceptable limits.
•Willingness to comply with all study procedures, including follow-up visits at weeks 1, 6, 12, 16, 20, 24 and 36 after surgery.
•Patients with fractures extending into the articular surface of the distal tibial epiphysis may be included, provided that the fracture is deemed stable

排除标准

•Presence of open or high-energy fractures, multiple lower-limb fractures, or use of bone grafts.
•Fractures classified as 43-B or 43-C according to AO/OTA.
•Chronic alcoholism (defined as >14 standard drinks per week for men or >7 for women).
•Presence of metabolic disorders, including uncontrolled thyroid dysfunction, severe renal or hepatic pathology.
•Pathological fractures associated with osteoporosis, osteomyelitis, tumors, metastases, or rickets.
•Lower-limb contractures with functional impairment of grade II or higher.
•Pregnancy or intention to conceive during the study period.
•Psychiatric, cognitive, or neurological disorders that may interfere with adherence to the rehabilitation protocol or effective communication with the study team.
•Clinically significant heart failure (including chronic or acute, with an ejection fraction <40% or with symptoms such as edema, dyspnea at rest, or orthopnea).
•Pulmonary insufficiency of any origin, accompanied by chronic hypoxemia (PaO₂ < 60 mmHg) or hypercapnia (PaCO₂ > 45 mmHg), requiring oxygen support or significantly limiting physical activity.
•Clinically significant neurological disorders that may affect motor function, coordination, or physical activity (e.g., stroke with residual deficits, Parkinson's disease, multiple sclerosis, cerebral palsy).
•Diagnosed epilepsy or other seizure disorders not fully controlled by medication.
•Progressive neurodegenerative diseases (e.g., amyotrophic lateral sclerosis, Huntington's disease, dementia).
•Any sensory, balance, or vestibular disorders that may impair safe use of the investigational device.
•Participation in another clinical study within the past 6 months that could affect the results of the current study.
•Ongoing or planned use of medications known to affect bone healing.

研究组 & 干预措施

Control Group (Standard of Care)

No Intervention

Participants will follow the standard-of-care postoperative weight-bearing protocol according to AO Foundation clinical guidelines: "Partial weight-bearing with crutches is started as soon as the patient is able. Unrestricted weight bearing should be delayed until fracture callus is visible, fibular healing is evident, and weight bearing is without pain. Depending on the consolidation, weight bearing can usually be increased after 6-8 weeks, with full weight-bearing when the fracture has healed." Smart Crutch Tips™ will be used in passive mode, with all notifications (audio and visual) disabled. Participants will not have access to any feedback regarding their weight-bearing. The devices will serve solely for data collection purposes, recording step count and applied loading during ambulation.

Controlled Mechanical Stimulation and Activity (Optimal Interfragmentary Motion)

Experimental

Participants will receive individualized weight-bearing prescriptions derived from finite element analysis (FEA) of their postoperative CT scan, targeting optimal interfragmentary motion at the fracture site.